NCT02608580View on ClinicalTrials.gov

Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2013

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Sickle Cell Disease
Interventions
OTHER

Survey

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT02608580 - Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital. | Biotech Hunter | Biotech Hunter